Reducing the Impact of Chronic Kidney Disease (CKD): Opportunities for Randomized Clinical Trials
Event Details Agenda
- Discuss critical elements of the study design to optimize the conduct and impact of Phase III clinical trials in CKD.
- Identify interventions and therapies for CKD that are currently in clinical trials or are ready to be evaluated in clinical trials.
- Discuss mechanisms for pathways of cooperation among industry, academia, government, and patient advocacy groups for CKD trials.